Clinical Research Directory
Browse clinical research sites, groups, and studies.
PRP as Adjuvant Treatment to CTR for Severe CTS Tunnel Syndrome
Sponsor: Michael Fredericson, MD
Summary
This study assesses the potential benefit of adjuvant platelet-rich plasma (PRP) with carpal tunnel release (CTR) for patients with severe carpal tunnel syndrome (CTS). CTR is a rather common procedure performed and seems to be quite effective for those with moderate CTS, but a number of patients with severe CTS do not have quite the same response post-CTR. The investigators will recruit patients who fall into the severe CTS category and compare CTR with and without adjuvant PRP to see if PRP can improve outcomes of this common surgery.
Official title: Utilizing Platelet-Rich Plasma as an Adjuvant to Carpal Tunnel Release for Severe Carpal Tunnel Syndrome
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2021-10-15
Completion Date
2025-07-01
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
Carpal Tunnel Release with Platelet-Rich Plasma
CTR is performed with adjuvant PRP placed intra-operatively.
Carpal Tunnel Release without Platelet-Rich Plasma
CTR is performed without adjuvant PRP placed intra-operatively.
Locations (1)
Stanford University
Redwood City, California, United States